| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.48B | 53.61B | 50.60B | 55.36B | 49.89B | 40.65B |
| Gross Profit | 8.36B | 8.18B | 6.84B | 7.29B | 7.23B | 6.65B |
| EBITDA | 5.33B | 5.20B | 4.00B | 4.50B | 3.87B | 3.75B |
| Net Income | 1.38B | 1.54B | 546.00M | 977.00M | 1.40B | 1.00B |
Balance Sheet | ||||||
| Total Assets | 67.69B | 67.86B | 69.94B | 67.95B | 66.49B | 58.42B |
| Cash, Cash Equivalents and Short-Term Investments | 5.45B | 5.90B | 6.75B | 6.08B | 7.50B | 9.29B |
| Total Debt | 27.84B | 28.58B | 30.26B | 29.94B | 28.18B | 24.59B |
| Total Liabilities | 47.07B | 46.78B | 50.78B | 50.19B | 49.58B | 43.30B |
| Stockholders Equity | 20.54B | 20.99B | 19.08B | 17.69B | 16.81B | 15.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 450.00M | 1.40B | -3.15B | -5.03B | -839.00M |
| Operating Cash Flow | 0.00 | 3.30B | 3.40B | 1.70B | -572.00M | 2.46B |
| Investing Cash Flow | 0.00 | -2.55B | -1.93B | -4.59B | -4.50B | -3.31B |
| Financing Cash Flow | 0.00 | -1.86B | -900.00M | 1.42B | 3.11B | 1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥31.64B | 15.35 | ― | 3.84% | -3.41% | -12.83% | |
69 Neutral | ¥16.25B | 9.49 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥16.76B | 13.84 | ― | 2.78% | 1.30% | -5.03% | |
66 Neutral | ¥26.45B | 13.86 | ― | 4.62% | 7.19% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥8.61B | 50.96 | ― | 1.35% | -2.76% | -25.24% | |
61 Neutral | ¥30.87B | 18.07 | ― | 4.27% | 5.72% | 28.92% |